0.00Open36.67Pre Close0 Volume0 Open Interest115.00Strike Price0.00Turnover171.87%IV-2.55%PremiumDec 20, 2024Expiry Date38.62Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9860Delta0.0031Gamma1.99Leverage Ratio-0.0356Theta-0.0061Rho-1.96Eff Leverage0.0029Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet